• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将抗原递送至CD40可诱导针对肿瘤的保护性免疫反应。

Delivery of antigen to CD40 induces protective immune responses against tumors.

作者信息

Schjetne Karoline W, Fredriksen Agnete B, Bogen Bjarne

机构信息

Institute of Immunology, University of Oslo and Rikshospitalet-Radiumhospitalet Medical Center, N-0027 Oslo, Norway.

出版信息

J Immunol. 2007 Apr 1;178(7):4169-76. doi: 10.4049/jimmunol.178.7.4169.

DOI:10.4049/jimmunol.178.7.4169
PMID:17371973
Abstract

Ligation of CD40 induces maturation of dendritic cells (DC) and could be a useful target for vaccines. In this study, we have constructed two types of Ab-based vaccine constructs that target mouse CD40. One type is a recombinant Ab with V regions specific for CD40 and has defined T cell epitopes inserted into its C region. The other type is a homodimer, each chain of which is composed of a targeting unit (single-chain fragment variable targeting CD40), a dimerization motif, and an antigenic unit. Such proteins bound CD40, stimulated maturation of DC, and enhanced primary and memory T cell responses. When delivered i.m. as naked DNA followed by electroporation, the vaccines induced T cell responses against MHC class II-restricted epitopes, Ab responses, and protection in two tumor models (myeloma and lymphoma). Two factors apparently contributed to these results: 1) agonistic ligation of CD40 and induction of DC maturation, and 2) delivery of Ag to APC and presentation on MHC class II molecules. These results highlight the importance of agonistic targeting of Ag to CD40 for induction of long-lasting and protective immune responses.

摘要

CD40的连接可诱导树突状细胞(DC)成熟,可能是疫苗的一个有用靶点。在本研究中,我们构建了两种靶向小鼠CD40的基于抗体的疫苗构建体。一种类型是具有针对CD40的V区的重组抗体,并在其C区插入了确定的T细胞表位。另一种类型是同二聚体,其每条链由一个靶向单元(靶向CD40的单链可变片段)、一个二聚化基序和一个抗原单元组成。这类蛋白质结合CD40,刺激DC成熟,并增强初始和记忆性T细胞反应。当作为裸DNA经肌肉注射后进行电穿孔给药时,这些疫苗在两种肿瘤模型(骨髓瘤和淋巴瘤)中诱导了针对MHC II类限制性表位的T细胞反应、抗体反应和保护作用。显然有两个因素促成了这些结果:1)CD40的激动性连接和DC成熟的诱导,以及2)将抗原递呈给抗原提呈细胞并在MHC II类分子上呈递。这些结果突出了将抗原激动性靶向CD40对于诱导持久和保护性免疫反应的重要性。

相似文献

1
Delivery of antigen to CD40 induces protective immune responses against tumors.将抗原递送至CD40可诱导针对肿瘤的保护性免疫反应。
J Immunol. 2007 Apr 1;178(7):4169-76. doi: 10.4049/jimmunol.178.7.4169.
2
CD40/APC-specific antibodies with three T-cell epitopes loaded in the constant domains induce CD4+ T-cell responses.载有三个 T 细胞表位的 CD40/APC 特异性抗体在恒定区诱导 CD4+ T 细胞应答。
Protein Eng Des Sel. 2012 Mar;25(3):89-96. doi: 10.1093/protein/gzr063. Epub 2012 Jan 10.
3
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.载药 PLGA 纳米粒疫苗经 CD40 靶向树突状细胞投递诱导强烈的抗肿瘤反应。
Biomaterials. 2015 Feb;40:88-97. doi: 10.1016/j.biomaterials.2014.10.053. Epub 2014 Nov 26.
4
DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.DNA疫苗通过将新型融合蛋白靶向抗原呈递细胞来提高独特型肿瘤抗原的免疫原性。
Mol Ther. 2006 Apr;13(4):776-85. doi: 10.1016/j.ymthe.2005.10.019. Epub 2006 Jan 18.
5
Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.电穿孔作为一种针对肿瘤抗原的裸DNA疫苗接种的“初免/加强”策略。
J Immunol. 2005 May 15;174(10):6292-8. doi: 10.4049/jimmunol.174.10.6292.
6
CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8+ T cells independently of IL-12.CD40的激活可增强产生IFN-γ的CD4⁺和CD8⁺T细胞的抗原呈递朗格汉斯细胞启动,且不依赖于IL-12。
J Immunol. 2004 Aug 15;173(4):2443-52. doi: 10.4049/jimmunol.173.4.2443.
7
CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation.CD40诱导的细胞表面MHC II类分子和CD80聚集导致抗原呈递的早期增强。
J Immunol. 2003 Dec 15;171(12):6478-87. doi: 10.4049/jimmunol.171.12.6478.
8
Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies.通过使用II类主要组织相容性复合体特异性特洛伊体将T细胞表位高效递送至抗原呈递细胞。
J Immunol. 2002 Mar 1;168(5):2154-62. doi: 10.4049/jimmunol.168.5.2154.
9
Vaccination with immature dendritic cells combined with CD40mAb induces protective immunity against B lymphoma in hu-SCID mice.不成熟树突状细胞联合 CD40mAb 疫苗接种诱导 hu-SCID 小鼠抗 B 淋巴瘤的保护性免疫。
Biomed Pharmacother. 2010 Sep;64(7):487-92. doi: 10.1016/j.biopha.2010.01.004. Epub 2010 Mar 4.
10
Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.摄取抗原特异性树突状细胞释放的外泌体的非特异性CD4(+) T细胞刺激抗原特异性CD8(+) CTL反应和长期T细胞记忆。
J Leukoc Biol. 2007 Oct;82(4):829-38. doi: 10.1189/jlb.0407249. Epub 2007 Jul 11.

引用本文的文献

1
Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform.利用基于CD40-卷曲螺旋亲和力的平台将抗原肽递送至抗原呈递细胞。
Drug Deliv. 2025 Dec;32(1):2486340. doi: 10.1080/10717544.2025.2486340. Epub 2025 May 26.
2
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors.通过靶向树突状细胞受体控制治疗性癌症疫苗中的抗原命运
Mol Pharm. 2023 Oct 2;20(10):4826-4847. doi: 10.1021/acs.molpharmaceut.3c00330. Epub 2023 Sep 18.
3
Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine.
针对新抗原的 APC 表面分子提高了 DNA 癌症疫苗的免疫原性和抗肿瘤疗效。
Front Immunol. 2023 Aug 29;14:1234912. doi: 10.3389/fimmu.2023.1234912. eCollection 2023.
4
Id-neoantigen vaccine induces therapeutic CD8 T cells against multiple myeloma: H chain-loss escapees cause FLC MM.Id 新抗原疫苗诱导针对多发性骨髓瘤的治疗性 CD8 T 细胞:重链缺失逃逸导致游离轻链 MM。
J Immunother Cancer. 2023 Aug;11(8). doi: 10.1136/jitc-2023-006944.
5
Nanomaterials-Mediated Co-Stimulation of Toll-Like Receptors and CD40 for Antitumor Immunity.纳米材料介导 Toll 样受体和 CD40 的共刺激作用增强抗肿瘤免疫。
Adv Mater. 2022 Nov;34(47):e2207486. doi: 10.1002/adma.202207486. Epub 2022 Oct 17.
6
STxB as an Antigen Delivery Tool for Mucosal Vaccination.STxB 作为黏膜疫苗接种的抗原传递工具。
Toxins (Basel). 2022 Mar 10;14(3):202. doi: 10.3390/toxins14030202.
7
CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model.CRISPR/Cas9介导的Foxp1基因沉默在具有免疫活性的A20淋巴瘤模型中恢复免疫监视功能。
Front Oncol. 2020 Apr 3;10:448. doi: 10.3389/fonc.2020.00448. eCollection 2020.
8
A DNA Vaccine That Encodes an Antigen-Presenting Cell-Specific Heterodimeric Protein Protects against Cancer and Influenza.一种编码抗原呈递细胞特异性异二聚体蛋白的DNA疫苗可预防癌症和流感。
Mol Ther Methods Clin Dev. 2020 Jan 25;17:378-392. doi: 10.1016/j.omtm.2020.01.007. eCollection 2020 Jun 12.
9
TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs.TLR3 激动剂和 CD40 靶向疫苗接种可诱导免疫应答并减少 HIV-1 储存库。
J Clin Invest. 2018 Oct 1;128(10):4387-4396. doi: 10.1172/JCI99005. Epub 2018 Aug 27.
10
Dendritic Cells in the Cross Hair for the Generation of Tailored Vaccines.用于定制疫苗生成的关键靶点——树突状细胞
Front Immunol. 2018 Jun 27;9:1484. doi: 10.3389/fimmu.2018.01484. eCollection 2018.